首頁 > 市場調查報告書 > 醫療設備

體外診斷

感染疾病診斷市場規模、佔有率和成長分析：按檢體類型、產品類型、檢測類型、疾病類型、技術、最終用戶和地區分類 - 2026-2033 年行業預測

市場調查報告書

商品編碼

1973579

感染疾病診斷市場規模、佔有率和成長分析：按檢體類型、產品類型、檢測類型、疾病類型、技術、最終用戶和地區分類 - 2026-2033 年行業預測

Infectious Disease Diagnostics Market Size, Share, and Growth Analysis, By Sample Type (Blood, Serum), By Product, By Testing Type, By Disease Type, By Technology, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月27日 | 出版商:

SkyQuest | 英文 186 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024年全球感染疾病診斷市值為229.4億美元，預計將從2025年的248.2億美元成長到2033年的466.3億美元。預測期（2026-2033年）的複合年成長率預計為8.2%。

受感染疾病流行率上升和分子診斷技術進步的推動，全球感染疾病診斷市場正經歷顯著成長。遠距遠端醫療的普及、就地檢驗需求的顯著成長以及公眾對感染疾病認知的提高，都為這一成長提供了動力。愛滋病、結核病和病毒感染疾病爆發等新出現的健康威脅正在推動市場擴張，而PCR、次世代定序（NGS）和基於CRISPR的診斷技術等創新在其中發揮關鍵作用。便利性、快速出結果和低基礎設施需求是照護現場解決方案廣受歡迎的原因。診斷公司與數位醫療公司之間的合作正在改善物流，而遠端醫療服務的興起則滿足了日益成長的居家檢測需求。然而，高成本、監管挑戰和基礎設施限制可能會阻礙市場更廣泛的滲透。

全球感染疾病診斷市場按產品、檢測類型、檢體類型、疾病類型、技術、最終用戶和地區進行細分。依產品分類，市場分為試劑、試劑盒及耗材、儀器、軟體及服務。按檢測類型分類，市場分為檢查室檢測和即時檢測（POC）。依檢體類型分類，市場分為血液、血清和血漿、尿液以及其他檢體類型。依疾病類型分類，市場分為肝炎、愛滋病、醫院感染、蚊媒疾病、人類乳突病毒（HPV）、披衣菌感染披衣菌、淋病、結核病、流感、梅毒等感染疾病。依技術分類，市場分為免疫診斷、臨床微生物學、聚合酵素鏈鎖反應（PCR）、恒溫核酸增幅技術、DNA定序和次世代定序、DNA微陣列等技術。按最終用戶分類，可分為診斷檢查室、醫院和診所、學術研究機構以及其他最終用戶。依地區分類，可分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

推動全球感染疾病診斷市場發展的因素

全球感染疾病診斷市場的主要促進因素之一是感染疾病的日益普及和公眾健康意識的提高。隨著包括呼吸道感染疾病、性行為感染感染和蟲媒感染疾病在內的各種感染疾病率的上升，對快速、準確的診斷工具的需求也日益成長。此外，分子檢測和就地檢驗設備等診斷技術的進步，有助於及時診斷並改善患者預後。各國政府和相關組織加大對醫療基礎設施和研究活動的投入，致力於加強感染疾病防治措施，進一步推動了市場的發展。

全球感染疾病診斷市場面臨的限制因素

全球感染疾病診斷市場的主要限制因素之一是先進診斷技術和設備的高成本。尤其是在發展中地區，許多醫療機構無法撥出足夠的預算來購買和維護最先進的診斷工具，這限制了患者獲得全面檢測的機會。此外，嚴格的監管要求和冗長的核准流程也減緩了新診斷測試的市場推廣速度，阻礙了市場成長。在某些地區，操作先進診斷系統的熟練人員短缺也是一個挑戰，最終影響感染疾病防治的整體效率和效果。

全球感染疾病診斷市場趨勢

在全球感染疾病診斷市場，一個顯著的趨勢是採用多重檢測和症候群檢測組合，這種組合能夠同時從單一檢體中檢測多種感染疾病。這項創新技術在呼吸道感染、胃腸道感染和性行為感染感染疾病的診斷方面尤其引人注目，並且在急診室、加護病房等關鍵醫療機構以及感染疾病爆發期間發揮著極其重要的作用。隨著醫療機構優先考慮成本效益和簡化工作流程，對這些先進多重檢測組合的需求預計將快速成長，感染疾病管理領域也明顯轉向全面、快速的診斷解決方案。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場公司採取的策略
近期市場趨勢
企業市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 2023-2025年營收年比比較

主要企業簡介

F. Hoffmann-La Roche Ltd.
Abbott
bioMerieux
Siemens Healthineers AG
Danaher
Thermo Fisher Scientific Inc.
Hologic, Inc.
Becton, Dickinson and Company
Qiagen
Seegene Inc.
Grifols, SA
DiaSorin SpA
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Co-Diagnostics, Inc.
Trinity Biotech
Genetic Signatures Ltd.
QuidelOrtho Corporation
Revvity
OraSure Technologies

結論與建議

簡介目錄

Product Code: SQMIG35D2341

Global Infectious Disease Diagnostics Market size was valued at USD 22.94 Billion in 2024 and is poised to grow from USD 24.82 Billion in 2025 to USD 46.63 Billion by 2033, growing at a CAGR of 8.2% during the forecast period (2026-2033).

The global infectious disease diagnostics market is experiencing significant growth, driven by a rise in the prevalence of infectious diseases and advancements in molecular diagnostics. There is a notable demand for point-of-care testing and heightened awareness of infectious diseases, alongside the increased adoption of telemedicine. Emerging health threats like HIV, tuberculosis, and viral outbreaks stimulate market expansion, with innovations in technologies such as PCR, NGS, and CRISPR-based diagnostics playing a crucial role. The appeal of convenience, rapid results, and minimal infrastructure requirements enhances the popularity of point-of-care solutions. Collaborations between diagnostic companies and digital health firms improve logistics, while the rise of telehealth services meets growing demands for at-home testing. However, high costs, regulatory challenges, and infrastructure limitations may hinder broader market penetration.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infectious Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infectious Disease Diagnostics Market Segments Analysis

Global infectious disease diagnostics market is segmented by product, testing type, sample type, disease type, technology, end user and region. Based on product, the market is segmented into reagents, kits, and consumables, instruments, and software & services. Based on testing type, the market is segmented into laboratory testing and POC Testing. Based on sample type, the market is segmented into blood, serum, and plasma, urine and other sample types. Based on disease type, the market is segmented into hepatitis, HIV, hospital-acquired infections, mosquito-borne diseases, HPV, Chlamydia Trachomatis, Neisseria Gonorrhea, Tuberculosis, Influenza, Syphilis, and other infectious diseases. Based on technology, the market is segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & next-generation sequencing, DNA microarray, and other technologies. Based on end user, the market is segmented into diagnostic laboratories, hospitals & clinics, academic research institutes, and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Infectious Disease Diagnostics Market

One of the key market drivers for the global infectious disease diagnostics market is the increasing prevalence of infectious diseases coupled with rising public health awareness. With the growing incidence of various infectious diseases like respiratory infections, sexually transmitted diseases, and vector-borne diseases, there is a heightened demand for rapid and accurate diagnostic tools. Additionally, advancements in diagnostic technologies, such as molecular testing and point-of-care devices, are facilitating timely diagnoses and better patient outcomes. Increased investment in healthcare infrastructure and research initiatives further propels the market, as governments and organizations focus on combating infectious diseases more effectively.

Restraints in the Global Infectious Disease Diagnostics Market

One significant market restraint for the Global Infectious Disease Diagnostics Market is the high cost associated with advanced diagnostic technologies and equipment. Many healthcare facilities, particularly in developing regions, struggle to allocate sufficient budgets for purchasing and maintaining state-of-the-art diagnostic tools, which limits access to comprehensive testing. Additionally, stringent regulatory requirements and lengthy approval processes can delay the introduction of new diagnostic tests to the market, further hampering growth. The lack of skilled personnel to operate sophisticated diagnostic systems in certain areas also poses a challenge, ultimately affecting the overall efficiency and effectiveness of infectious disease management.

Market Trends of the Global Infectious Disease Diagnostics Market

The Global Infectious Disease Diagnostics market is witnessing a significant trend towards the adoption of multiplex and syndromic testing panels, which enable the simultaneous detection of multiple pathogens from a single sample. This innovation is gaining traction, especially for diagnosing respiratory, gastrointestinal, and sexually transmitted infections, making it highly valuable in critical healthcare settings such as emergency departments and intensive care units, as well as during outbreak situations. As healthcare facilities increasingly prioritize cost-efficiency and streamline workflows, the demand for these advanced multiplex molecular panels is poised for accelerated growth, highlighting a shift towards comprehensive and rapid diagnostic solutions in infectious disease management.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Infectious Disease Diagnostics Market Size by Product & CAGR (2026-2033)

Market Overview
Reagents & Kits
Instruments
Software & Services

Global Infectious Disease Diagnostics Market Size by Testing Type & CAGR (2026-2033)

Market Overview
Laboratory Testing
Point-of-Care Testing

Global Infectious Disease Diagnostics Market Size by Sample Type & CAGR (2026-2033)

Market Overview
Blood & Plasma
Urine
Other Samples

Global Infectious Disease Diagnostics Market Size by Disease Type & CAGR (2026-2033)

Market Overview
Hepatitis
HIV
Tuberculosis
Influenza
Other Infectious Diseases
- Hospital-Acquired Infections
- Mosquito-Borne Diseases
- HPV
- Chlamydia
- Gonorrhea
- Syphilis

Global Infectious Disease Diagnostics Market Size by Technology & CAGR (2026-2033)

Market Overview
Immunodiagnostics
Clinical Microbiology
Nucleic Acid Amplification
- Polymerase Chain Reaction
- Isothermal Amplification
DNA Technologies
- Sequencing
- Microarray

Global Infectious Disease Diagnostics Market Size by End User & CAGR (2026-2033)

Market Overview
Diagnostic Laboratories
Hospitals & Clinics
Research Institutes
Other End Users

Global Infectious Disease Diagnostics Market Size & CAGR (2026-2033)

North America (Product, Testing Type, Sample Type, Disease Type, Technology, End User)
- US
- Canada
Europe (Product, Testing Type, Sample Type, Disease Type, Technology, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Testing Type, Sample Type, Disease Type, Technology, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Testing Type, Sample Type, Disease Type, Technology, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Testing Type, Sample Type, Disease Type, Technology, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Co-Diagnostics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trinity Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genetic Signatures Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments